REHOVOT, ISRAEL
Pharmaceuticals
2
$3.38M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-02-19 | New offering first sale 2026-02-11 | $3.38M | $3.38M | SEC filing |
| 2024-09-04 | New offering first sale 2024-08-23 | $0 | $12.02M | SEC filing |
Keep reading
More on Evogene Ltd. and the records around it.
Evogene Ltd. elsewhere on the record
- 5%+ stake filings Oct 2026
- Form D filing Feb 2026
- Who owns it
Companies that share a holder
- RECANATI LEON also filed stake reports on 1 other company: KAMADA LTD (Mar 2026)
- L.I.A. Pure Capital Ltd. also filed stake reports on 10 other companies: Quantum X Labs Inc. (formerly known as Viewbix Inc.) (Aug 2026), Rail Vision Ltd. (Aug 2026), Clearmind Medicine Inc. (May 2026)
- Armistice Capital, LLC also filed stake reports on 120 other companies: Arcadia Biosciences, Inc. (Aug 2026), Aridis Pharmaceuticals, Inc. (Aug 2026), Autolus Therapeutics plc (Aug 2026)
Watch Evogene Ltd.
Get an email when Evogene Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Evogene Ltd.?
Who to contact
- Ofer Haviv — President and Chief Executive Officer and Director
- Yaron Eldad — Chief Financial Officer
- Gabi Tarcic — Vice President Product
- Ilia Zhidkov — Vice President Computational Platform
- Nir Nimrodi — Chairperson of the Board
- Sarit Firon — Director
- Dan Falk — Director
- Adrian Percy — Director
- Leon Recanati — Director
- Round: Form D filed 2026-02-19
- Amount sold: $3.38M
- Industry: Pharmaceuticals
- Based: REHOVOT, ISRAEL
People listed
- Ofer Haviv — President and Chief Executive Officer and Director
- Yaron Eldad — Chief Financial Officer
- Gabi Tarcic — Vice President Product
- Ilia Zhidkov — Vice President Computational Platform
- Nir Nimrodi — Chairperson of the Board
- Sarit Firon — Director
- Dan Falk — Director
- Adrian Percy — Director
- Leon Recanati — Director
- Filing: Form D filed 2026-02-19
- Amount sold: $3.38M
- Industry group: Pharmaceuticals
- Based: REHOVOT, ISRAEL
- Entity type: Corporation
We'll show it in your MentionFox inbox when Evogene Ltd. raises, hires or launches. No email unless you switch it on.
Watch Evogene Ltd. →Want the whole picture on Evogene Ltd.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Evogene Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Evogene Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
2 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Evogene Ltd.'s own filings with the SEC. The people those filings name are on the team page.